UniProt ID | PRP19_MOUSE | |
---|---|---|
UniProt AC | Q99KP6 | |
Protein Name | Pre-mRNA-processing factor 19 {ECO:0000305} | |
Gene Name | Prpf19 {ECO:0000312|MGI:MGI:106247} | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 504 | |
Subcellular Localization | Isoform 1: Nucleus . Nucleus, nucleoplasm . Cytoplasm, cytoskeleton, spindle . Cytoplasm . Lipid droplet . Nucleoplasmic in interphase cells. Irregularly distributed in anaphase cells. In prophase cells, uniformly distributed, but not associated with | |
Protein Description | Isoform 1: Ubiquitin-protein ligase which is a core component of several complexes mainly involved in pre-mRNA splicing and DNA repair. Core component of the PRP19C/Prp19 complex/NTC/Nineteen complex which is part of the spliceosome and participates in its assembly, its remodeling and is required for its activity. During assembly of the spliceosome, mediates 'Lys-63'-linked polyubiquitination of the U4 spliceosomal protein PRPF3. Ubiquitination of PRPF3 allows its recognition by the U5 component PRPF8 and stabilizes the U4/U5/U6 tri-snRNP spliceosomal complex. Recruited to RNA polymerase II C-terminal domain (CTD) and the pre-mRNA, it may also couple the transcriptional and spliceosomal machineries. The XAB2 complex, which contains PRPF19, is also involved in pre-mRNA splicing, transcription and transcription-coupled repair. Beside its role in pre-mRNA splicing PRPF19, as part of the PRP19-CDC5L complex, plays a role in the DNA damage response/DDR. It is recruited to the sites of DNA damage by the RPA complex where PRPF19 directly ubiquitinates RPA1 and RPA2. 'Lys-63'-linked polyubiquitination of the RPA complex allows the recruitment of the ATR-ATRIP complex and the activation of ATR, a master regulator of the DNA damage response. May also play a role in DNA double-strand break (DSB) repair by recruiting the repair factor SETMAR to altered DNA. As part of the PSO4 complex may also be involved in the DNA interstrand cross-links/ICLs repair process. In addition, may also mediate 'Lys-48'-linked polyubiquitination of substrates and play a role in proteasomal degradation. [PubMed: 17349974 May play a role in the biogenesis of lipid droplets] | |
Protein Sequence | MSLICSISNEVPEHPCVSPVSNHVYERRLIEKYIAENGTDPINNQPLSEEQLIDIKVAHPIRPKPPSATSIPAILKALQDEWDAVMLHSFTLRQQLQTTRQELSHALYQHDAACRVIARLTKEVTAAREALATLKPQAGLIVPQAVPSSQPSVVGAGEPMDLGELVGMTPEIIQKLQDKATVLTTERKKRGKTVPEELVKPEELSKYRQVASHVGLHSASIPGILALDLCPSDTNKILTGGADKNVVVFDKSTEQILATLKGHTKKVTSVVFHPSQELVFSASPDATIRIWSVPNTSCVQVVRAHESAVTGLSLHATGDYLLSSSDDQYWAFSDIQTGRVLTKVTDETSGCSLTCAQFHPDGLIFGTGTMDSQIKIWDLKERTNVANFPGHSGPITSIAFSENGYYLATAADDSSVKLWDLRKLKNFKTLQLDNNFEVKSLIFDQSGTYLALGGTDVQIYICKQWTEILHFTEHSGLTTGVAFGHHAKFIASTGMDRSLKFYSL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSLICSISN ------CCEEEECCC | 26.83 | 26643407 | |
2 | Acetylation | ------MSLICSISN ------CCEEEECCC | 26.83 | - | |
6 | Phosphorylation | --MSLICSISNEVPE --CCEEEECCCCCCC | 23.27 | 26643407 | |
8 | Phosphorylation | MSLICSISNEVPEHP CCEEEECCCCCCCCC | 15.62 | 26643407 | |
18 | Phosphorylation | VPEHPCVSPVSNHVY CCCCCCCCCCCCHHH | 26.71 | 26643407 | |
21 | Phosphorylation | HPCVSPVSNHVYERR CCCCCCCCCHHHHHH | 25.30 | 26643407 | |
25 | Phosphorylation | SPVSNHVYERRLIEK CCCCCHHHHHHHHHH | 9.00 | 26643407 | |
37 | Ubiquitination | IEKYIAENGTDPINN HHHHHHHHCCCCCCC | 50.03 | 27667366 | |
48 | Phosphorylation | PINNQPLSEEQLIDI CCCCCCCCHHHCEEE | 45.85 | 29899451 | |
64 | Ubiquitination | VAHPIRPKPPSATSI ECCCCCCCCCCCCCH | 60.76 | 22790023 | |
114 | S-nitrosocysteine | LYQHDAACRVIARLT HHHHHHHHHHHHHHH | 3.70 | - | |
114 | S-nitrosylation | LYQHDAACRVIARLT HHHHHHHHHHHHHHH | 3.70 | 20925432 | |
122 | Acetylation | RVIARLTKEVTAARE HHHHHHHHHHHHHHH | 55.57 | - | |
122 | Ubiquitination | RVIARLTKEVTAARE HHHHHHHHHHHHHHH | 55.57 | 22790023 | |
141 | Ubiquitination | LKPQAGLIVPQAVPS HCCCCCEECCCCCCC | 4.09 | 27667366 | |
159 | Ubiquitination | SVVGAGEPMDLGELV CCCCCCCCCCHHHHC | 22.22 | 27667366 | |
179 | Acetylation | IIQKLQDKATVLTTE HHHHHHHHCEEEECH | 32.75 | 23806337 | |
181 | Phosphorylation | QKLQDKATVLTTERK HHHHHHCEEEECHHH | 23.07 | 19854140 | |
192 | Malonylation | TERKKRGKTVPEELV CHHHHCCCCCCHHHC | 50.84 | 26320211 | |
244 | Ubiquitination | ILTGGADKNVVVFDK EECCCCCCCEEEEEC | 51.62 | 27667366 | |
244 | Acetylation | ILTGGADKNVVVFDK EECCCCCCCEEEEEC | 51.62 | 23806337 | |
244 | Malonylation | ILTGGADKNVVVFDK EECCCCCCCEEEEEC | 51.62 | 26320211 | |
251 | Ubiquitination | KNVVVFDKSTEQILA CCEEEEECCHHHHHH | 48.06 | 22790023 | |
251 | Acetylation | KNVVVFDKSTEQILA CCEEEEECCHHHHHH | 48.06 | 22826441 | |
261 | Ubiquitination | EQILATLKGHTKKVT HHHHHHHCCCCCEEE | 44.27 | 22790023 | |
261 | Acetylation | EQILATLKGHTKKVT HHHHHHHCCCCCEEE | 44.27 | 22826441 | |
263 | Ubiquitination | ILATLKGHTKKVTSV HHHHHCCCCCEEEEE | 32.69 | 27667366 | |
266 | Ubiquitination | TLKGHTKKVTSVVFH HHCCCCCEEEEEEEC | 52.48 | 22790023 | |
503 | Phosphorylation | DRSLKFYSL------ CCCCEEECC------ | 30.64 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PRP19_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PRP19_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRP19_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PRS8_MOUSE | Psmc5 | physical | 17349974 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...